KBC Group NV - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
KBC Group NV ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1590.0%2,7700.0%0.00%0.0%
Q2 2023$159
+33.6%
2,770
-12.8%
0.00%0.0%
Q1 2023$119
+33.7%
3,1780.0%0.00%
Q4 2022$89
-99.9%
3,1780.0%0.00%
Q3 2022$89,000
-19.8%
3,1780.0%0.00%
-100.0%
Q2 2022$111,000
-86.3%
3,178
-92.4%
0.00%
-80.0%
Q4 2019$811,000
-2.6%
42,0190.0%0.01%
-16.7%
Q3 2019$833,000
-6.1%
42,0190.0%0.01%
-14.3%
Q2 2019$887,000
-21.9%
42,019
-24.4%
0.01%
-22.2%
Q1 2019$1,136,000
+2.6%
55,6070.0%0.01%
-25.0%
Q4 2018$1,107,000
-19.7%
55,607
-22.4%
0.01%
+20.0%
Q3 2018$1,379,000
+41.4%
71,653
+12.2%
0.01%
+25.0%
Q2 2018$975,000
-15.1%
63,871
+4.3%
0.01%
-27.3%
Q1 2018$1,148,000
+29.7%
61,241
+33.1%
0.01%
+37.5%
Q4 2017$885,000
+7.7%
46,0160.0%0.01%
+14.3%
Q3 2017$822,0000.0%46,0160.0%0.01%
-12.5%
Q2 2017$822,000
+23.2%
46,0160.0%0.01%
+33.3%
Q1 2017$667,000
+22.6%
46,016
+55.7%
0.01%
+20.0%
Q4 2016$544,00029,5560.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders